Dabur India

Crisil has reaffirmed the high safety rating to Dabur India's Rs 20-crore non-convertible debenture (NCD) issue and its fixed deposit (FD) programme.

The ratings agency also reaffirmed the `P+1' rating assigned to the company's Rs 100-crore commercial paper programme, indicating highest safety. The ratings are said to factor in Dabur's strength in the ayurvedic healthcare and personal care market, its strong herbal over-the-counter (OTC) brands, well-established distribution network and its adequate multi-locational manufacturing facilities.